Banerjee Subhashis: insider trades.
Banerjee Subhashis reported 6 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($116K), across 1 company.
- Transactions
- 6
- Purchases (P)
- 0
- Sales (S)
- 3
- Companies
- 1
- Name as filed
- Banerjee Subhashis
Companies
| Company | Relationship | Transactions |
|---|---|---|
| Artiva Biotherapeutics, Inc. (ARTV) | Officer · Chief Medical Officer | 6 |
Transactions
| Date | Company | Code | Shares | Price | Owned after | Filing |
|---|---|---|---|---|---|---|
| 2026-09-09 | Artiva Biotherapeutics, Inc. | A | 30,000 | $0 | 170,947 | Form 4 |
| 2026-09-03 | Artiva Biotherapeutics, Inc. | S | 1,100 | $11.16 | 140,947 | Form 4 |
| 2026-08-27 | Artiva Biotherapeutics, Inc. | M | 5,306 | $1.92 | 150,269 | Form 4 |
| 2026-08-27 | Artiva Biotherapeutics, Inc. | S | 8,222 | $12.01 | 142,047 | Form 4 |
| 2026-08-18 | Artiva Biotherapeutics, Inc. | S | 429 | $12 | 144,963 | Form 4 |
| 2026-08-18 | Artiva Biotherapeutics, Inc. | M | 429 | $1.92 | 145,392 | Form 4 |
Questions
What stock did Banerjee Subhashis buy or sell?
Banerjee Subhashis reported 6 non-derivative transactions on 4 SEC ownership filings in Q3 2026: 0 open-market purchases and 3 sales ($116K), across 1 company.
Is Banerjee Subhashis the same person as other filers with this name?
This page covers SEC CIK 2065633 only. The SEC assigns each reporting owner a CIK, and people with the same name have different CIKs.
Source: SEC Insider Transactions Data Sets, Q3 2026. Reported as filed; we do not assess intent, performance or compliance. All filings for this CIK on SEC.gov.
Plain-text version for agents and LLMs: /insiders/banerjee-subhashis-2065633.md
Independent. Not affiliated with, endorsed by, or sponsored by the U.S. Securities and Exchange Commission. Data is reproduced from public SEC filings and datasets. Not investment advice.